QRL-101

N/A

Report date: 2026/02/25 20:02:36

Base Information

Drug NameQRL-101
Drug Alias NameQRL-101
ClassificationBiologics
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 stimulantsPotassium voltage-gated channel subfamily KQT member 3 stimulants
TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesQurAlis Corp
China Registration ClassN/A

Develop Information

Active CompaniesQurAlis Corp
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A